![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Achiron A. Barak Y. Noy S. Pinhas-Hamiel O.
Publisher: Elsevier
ISSN: 0924-977X
Source: European Neuropsychopharmacology, Vol.9, Iss.1, 1999-01, pp. : 111-113
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ciclosporin is effective in the treatment of patients with severe myasthenia gravis
Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Immunomodulatory treatment for myasthenia gravis
Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of Myasthenia Gravis: Focus on Pyridostigmine
By Maggi Lorenzo Mantegazza Renato
Clinical Drug Investigation, Vol. 31, Iss. 10, 2011-10 ,pp. :